MRIs are helpful for detecting early stages of numerous diseases, or abnormalities. In a recently published article in the Journal of Clinical Oncology, it appears that MRIs can be more effective than standard bone testing in detecting bone abnormalities in patients with multiple myeloma.
Multiple myeloma is cancer of the blood that affects the plasma cells, which are important to the immune system helping produce antibodies. Characterized by excess production of abnormal plasma cells; symptoms include increased risk of bacterial infections and impaired immune responses. This also affects the bone, diagnosed patients will experience low bone density, cancerous cells surrounding bone, and bone fractures.
For more information or to read the full article – click here.